🔗 Share this article

Texas Attorney General Ken Paxton is suing the makers of Tylenol, alleging the companies hid alleged dangers that the drug presented to pediatric brain development.

The lawsuit arrives four weeks after Donald Trump advocated an unproven link between using acetaminophen - referred to as paracetamol - throughout gestation and autism in offspring.

The attorney general is suing J&J, which formerly manufactured the drug, the only pain reliever recommended for pregnant women, and Kenvue, which presently makes it.

In a declaration, he claimed they "betrayed America by gaining financially from pain and marketing drugs regardless of the dangers."

The company states there is insufficient reliable data connecting acetaminophen to autism.

"These manufacturers misled for generations, knowingly endangering countless individuals to line their pockets," the attorney general, from the Republican party, stated.

The company commented that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the well-being of women and children in America."

On its website, the company also mentioned it had "consistently assessed the applicable studies and there is lacking reliable evidence that indicates a established connection between using acetaminophen and autism spectrum disorder."

Groups speaking for physicians and medical practitioners agree.

ACOG has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for women during pregnancy to manage discomfort and fever, which can create serious health risks if not addressed.

"In over twenty years of research on the consumption of paracetamol in gestation, no reliable research has definitively established that the usage of acetaminophen in any stage of pregnancy causes neurological conditions in offspring," the group commented.

This legal action mentions recent announcements from the previous government in claiming the medication is reportedly hazardous.

Recently, the former president generated worry from public health officials when he instructed women during pregnancy to "resist strongly" not to consume Tylenol when sick.

Federal regulators then issued a notice that medical professionals should consider limiting the usage of Tylenol, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would determine the cause of autism in a short period.

But authorities advised that identifying a unique factor of autism - thought by researchers to be the outcome of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and disability that impacts how persons experience and interact with the environment, and is recognized using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking the Senate - asserts the manufacturer and J&J "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "eliminate any promotional materials" that states Tylenol is reliable for women during pregnancy.

The court case mirrors the concerns of a collection of guardians of children with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in two years ago.

Judicial authorities rejected the legal action, stating investigations from the plaintiffs' authorities was not conclusive.